Hisamitsu Financial Statements From 2010 to 2024
HTSUF Stock | USD 24.56 0.00 0.00% |
Check Hisamitsu Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hisamitsu main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Hisamitsu financial statements analysis is a perfect complement when working with Hisamitsu Pharmaceutical Valuation or Volatility modules.
Hisamitsu |
Hisamitsu Pharmaceutical Co Company Profit Margin Analysis
Hisamitsu Pharmaceutical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Hisamitsu Pharmaceutical Profit Margin | 0.10 % |
Most of Hisamitsu Pharmaceutical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hisamitsu Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Hisamitsu Pharmaceutical Co has a Profit Margin of 0.1034%. This is 100.92% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 108.14% lower than that of the firm.
Hisamitsu Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hisamitsu Pharmaceutical competition to find correlations between indicators driving Hisamitsu Pharmaceutical's intrinsic value. More Info.Hisamitsu Pharmaceutical Co is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hisamitsu Pharmaceutical Co is roughly 2.38 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hisamitsu Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hisamitsu Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Hisamitsu Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Hisamitsu Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Hisamitsu Pharmaceutical investors use historical funamental indicators, such as Hisamitsu Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Hisamitsu Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Hisamitsu Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hisamitsu Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hisamitsu Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hisamitsu Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2784 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Hisamitsu Pink Sheet analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |